Menveo Side Effects

Generic name: meningococcal conjugate vaccine

Medically reviewed by Drugs.com. Last updated on Aug 14, 2024.

Note: This document provides detailed information about Menveo Side Effects associated with meningococcal conjugate vaccine. Some dosage forms listed on this page may not apply specifically to the brand name Menveo.

Applies to meningococcal conjugate vaccine: intramuscular suspension.

Other dosage forms:

• intramuscular solution

Serious side effects of Menveo

Along with its needed effects, meningococcal conjugate vaccine (the active ingredient contained in Menveo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking meningococcal conjugate vaccine:

More common

• chills
• fever
• general feeling of discomfort or illness
• unusual tiredness or weakness

Incidence not known

• back pain, sudden and severe
• blurred vision
• burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
• confusion
• cough
• difficulty with swallowing
• dizziness
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• fainting
• fast heartbeat
• flushing or redness of the skin
• hives or welts
• inability to move the arms and legs
• itching
• muscle weakness, sudden and progressing
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• seizures
• shortness of breath
• skin rash
• sudden numbness and weakness in the arms and legs
• sweating
• tightness in the chest
• unusually warm skin
• wheezing

Other side effects of Menveo

Some side effects of meningococcal conjugate vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• crying
• diarrhea
• difficulty with moving
• drowsiness
• irritability
• loss of appetite
• muscle pain or stiffness
• pain in the joints
• pain, redness, swelling, or tenderness at the injection site
• vomiting

For healthcare professionals

Applies to meningococcal conjugate vaccine: intramuscular powder for injection, intramuscular solution.

General

The most common adverse events were injection site pain, irritability, diarrhea, headache, and fatigue.^[Ref]

Local

• Very common (10% or more): Injection site pain (48.1%), injection site redness (16%), injection site induration (11%)
• Common (1% to 10%): Injection site swelling, injection site hematoma
• Uncommon (0.1% to 1%): Injection site pruritus
• Postmarketing reports: Injection site reaction, injection site cellulitis, extensive swelling of the injected limb (frequently associated with erythema, sometimes involving the adjacent joint or swelling of the entire injected limb)^[Ref]

Nervous system

• Very common (10% or more): Headache (41.8%), drowsiness (11.2%)
• Uncommon (0.1% to 1%): Dizziness, hypoesthesia
• Postmarketing reports: Vasovagal syncope, paresthesia, Guillain-Barre syndrome, vertigo, tonic convulsion, febrile convulsion, vertigo, vestibular disorder, syncope, facial paresis, balance disorder^[Ref]

Gastrointestinal

• Very common (10% or more): Diarrhea (14%), nausea
• Common (1% to 10%): Vomiting, gastrointestinal symptoms^[Ref]

Other

• Very common (10% or more): Fatigue (32.3%), malaise (22.3%), fever
• Common (1% to 10%): Chills, crying
• Postmarketing reports: Asthenia, impaired hearing, ear pain, fall, head injury, body temperature increased^[Ref]

Dermatologic

• Common (1% to 10%): Rash
• Uncommon (0.1% to 1%): Pruritus
• Postmarketing reports: Bullous conditions^[Ref]

Musculoskeletal

• Very common (10% or more): Arthralgia (16%), myalgia
• Uncommon (0.1% to 1%): Pain in extremity
• Postmarketing reports: Bone pain^[Ref]

Psychiatric

• Very common (10% or more): Irritability (12.2%)
• Common (1% to 10%): Insomnia^[Ref]

Metabolic

• Very common (10% or more): Appetite lost
• Common (1% to 10%): Anorexia, eating disorder^[Ref]

Respiratory

• Uncommon (0.1% to 1%): Nasopharyngitis
• Postmarketing reports: Oropharyngeal pain^[Ref]

Hypersensitivity

• Postmarketing reports: Hypersensitivity (such as rash, urticaria, pruritus, dyspnea, angioedema) including anaphylaxis^[Ref]

Hepatic

• Postmarketing reports: Alanine aminotransferase increased^[Ref]

Ocular

• Postmarketing reports: Eyelid ptosis^[Ref]

Further information

Menveo side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer